Malignant mixed epithelial and mesenchymal tumor of cervix uteri

Malignant mixed epithelial and mesenchymal tumor of the cervix uteri is an extremely rare gynecological malignancy that arises in the uterine cervix and contains both malignant epithelial (carcinomatous) and malignant mesenchymal (sarcomatous) components. These tumors are also referred to as malignant mixed Müllerian tumors (MMMTs) or carcinosarcomas of the cervix. They belong to a broader category of mixed tumors that can occur throughout the female genital tract, though cervical involvement is far less common than uterine corpus involvement. The disease primarily affects the reproductive system. Patients may present with abnormal vaginal bleeding (including postmenopausal bleeding), a cervical mass or polyp, pelvic pain, and vaginal discharge. Due to the aggressive nature of the tumor, which combines features of both carcinoma and sarcoma, the disease can spread locally to surrounding pelvic structures and metastasize to distant sites including the lungs, liver, and lymph nodes. Diagnosis typically requires histopathological examination demonstrating the biphasic nature of the tumor, with both epithelial and mesenchymal malignant elements. Given its extreme rarity, there are no standardized treatment protocols specific to this tumor. Management is generally extrapolated from experience with uterine carcinosarcomas and typically involves radical surgical resection (such as radical hysterectomy with bilateral salpingo-oophorectomy and pelvic lymph node dissection), often followed by adjuvant chemotherapy and/or radiation therapy. Platinum-based chemotherapy regimens are commonly employed. The prognosis is generally poor due to the aggressive biological behavior of these tumors, though outcomes depend on the stage at diagnosis. Early detection and multimodal treatment may improve survival.

Common questions about Malignant mixed epithelial and mesenchymal tumor of cervix uteri